Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Amedisys to Acquire Asana Hospice

Amedisys to Acquire Asana Hospice

Amedisys, Inc. America’s leading independent home health, hospice and personal care company, has signed a definitive agreement to acquire Asana Hospice.

Under the terms of the agreement, targeted to close on January 1, 2020, Amedisys will acquire 100 percent of the ownership interests in Asana Hospice. Asana provides hospice care to approximately 540 patients daily in eight locations in Pennsylvania, Ohio, Missouri, Kansas and Texas.

“I’m honored to welcome Asana Hospice’s dedicated and compassionate team to the Amedisys family of caregivers,” stated Amedisys CEO and President Paul Kusserow. “Our two organizations share a commitment to putting excellent patient care at the forefront of everything we do, and I know our strengthened family will continue to deliver clinical distinction to these communities for years to come.”

On the close of the agreement, Amedisys will operate 146 hospice care centers in 33 states, marking the third hospice acquisition for the Company in less than a year. Amedisys acquired and integrated Compassionate Care Hospice in February 2019 and RoseRock Healthcare in April 2019. These additions, with a combined average daily census of 3,500, expanded Amedisys’ hospice network into 54 new locations in 12 new states. Amedisys now cares for nearly 12,000 patients daily.

“Since our founding, Asana Hospice has focused on family and patient-centered care and empowering each and every team member to take part in fulfilling this mission,” stated David Glick, President and CEO of Asana Hospice. “In Amedisys, we find true alignment to our shared mission of providing the highest quality of care to the communities we serve.”

GE Healthcare Unveils Novel Contrast-Enhanced Mammography Solution for Biopsy

GE Healthcare Unveils Novel Contrast-Enhanced Mammography Solution for Biopsy

To help empower clinicians and patients in their fight against breast cancer, GE Healthcare today introduced Serena Bright™*, the healthcare industry’s first contrast-enhanced mammography solution for biopsy.

Interventional and biopsy procedures are a necessary step in most breast cancer diagnoses. Previously, for lesions not seen on mammography or ultrasound, contrast-enhanced biopsy was typically performed with breast MR, which can be more time-consuming, uncomfortable and costly for patients. With Serena Bright, breast biopsy exams can now be done with the same mammography equipment and in the same room as the screening or diagnostic mammogram. This can help save time, lessen costs and ultimately help improve the patient experience.

“This new mammography-guided biopsy technique offers an alternative to MR-guided breast biopsy, which can improve the patient experience and allow us to get answers to patients faster,” says Dr. Corinne Balleyguier, Head of Medical Imaging at Gustave Roussy in France. “We are proud to be the first in the world to be able to offer this technology to our patients and believe this will have a significant impact on breast imaging capabilities.”

Key to this revolutionary change in breast care is GE Healthcare’s SenoBright™ HD Contrast Enhanced Spectral Mammography (CESM), a diagnostic imaging tool that can detect malignant lesions not seen on mammography or ultrasound in certain cases. By highlighting areas of unusual blood flow to help localize lesions that need to be biopsied, CESM biopsy – Serena Bright – helps improve radiologists’ diagnostic confidence with the ultimate goal of getting answers to patients as quickly as possible.

“This novel approach has the potential to be a more affordable and faster alternative to MR-guided biopsy for suspect findings seen in CESM,” says Dr. Rodrigo Alcantara, Head of Breast Imaging Section at Hospital del Mar in Spain. “Our initial findings have been incredibly successful in reliably targeting enhancing lesions to ultimately find cancer earlier.”

“We are thrilled to introduce this industry-first solution to equip clinicians with another key tool in the fight against breast cancer,” adds Agnes Berzsenyi, President & CEO of Women’s Health at GE Healthcare. “Through a multi-modality and personalized approach, our hope is that we can find cancers earlier to ultimately improve outcomes and save lives.”

* 510k pending at FDA. Not available for sale in the United States.

About GE Healthcare:
GE Healthcare is the $19.8 billion healthcare business of GE. As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. Follow us on Facebook, LinkedIn, Twitter and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

Baxter to Expand Advanced Surgery Portfolio with Acquisition of Seprafilm Adhesion Barrier

Community Health Systems Announces Definitive Agreements to Sell Three Virginia Hospitals

Baxter International Inc ,a leading global medical products company,entered into a definitive agreement to acquire Seprafilm Adhesion Barrier and related assets from Sanofi. The agreement is the latest example of Baxter’s continued focus on acquiring products and technologies that have a strong strategic fit with the company’s leading portfolio across the hospital, including in the operating room. The transaction contemplates a cash purchase price at closing of $350 million and is expected to close no later than the first quarter of 2020, following satisfaction of closing conditions.

Seprafilm will be a strong complement to our leading hemostat and sealant portfolio, helping us continue to advance the art of healing with optimized patient care in the operating room,” said Wil Boren, general manager, Baxter’s Advanced Surgery business. “While Seprafilm is clinically recognized among surgeons globally, we plan to provide commercial support for the product through our dedicated surgery salesforce and pursue opportunities for expansion in certain countries.”

Adhesion prevention products, hemostats and sealants are important tools surgeons use to manage intraoperative bleeding and reduce adhesions. Adhesions can occur in any surgery1 when scar tissue develops and binds to nearby tissue. Adhesions can be a source of major post-surgical complications and often require revision, or a second surgery to remove the adhesions. Up to 93% of patients have been shown to develop adhesions following laparotomy,2 a large, surgical incision into the abdominal cavity. Approximately 20% of abdominal surgery patients return for adhesion-related complications, with annual surgical costs of more than $2 billion in the U.S. alone.3

Seprafilm currently has a global commercial presence including sales in the U.S., Japan, China, South Korea and France, among others. Sales of the proposed acquired products are expected to be approximately $100 million in the 12 months following close.

About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

ViewRay Announces Collaborations with Elekta and Medtronic

ViewRay Announces Collaborations with Elekta and Medtronic

ViewRay Inc announced that it has signed a non-binding memorandum of understanding for collaboration with Elekta AB to advance the knowledge and use of MR-guided radiation therapy. In connection with the collaboration, Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay, subject to the terms and conditions set forth in a commitment agreement.

Additionally, ViewRay has signed a non-binding memorandum of understanding with Medtronic to enter into a clinical collaboration in an area of mutual interest that includes exploring the clinical benefits of the MRIdian MR-guided radiation therapy system. In connection with the collaboration, Medtronic has committed to invest in a minority interest in ViewRay, subject to the terms and conditions set forth in a commitment agreement.

ViewRay’s largest shareholder, Fosun International Limited (“Fosun”), has also committed capital up to an amount that would enable it to maintain its current beneficial ownership percentage in ViewRay, subject to the terms and conditions set forth in a commitment agreement.

The investments from Elekta and Medtronic are conditioned upon the consummation of an equity capital raise of at least $75 million.

“We are pleased to announce these important collaborations and investments in ViewRay. Our goal is to concurrently prove the value of MR-guided radiation therapy and strengthen our balance sheet,” said Scott Drake, President and CEO of ViewRay. “We are well-positioned to drive MRIdian to standard of care. The ability to see clearly during the procedure, track tumors and soft tissues, and auto-gate the beam is integral to delivering highly precise, personalized medicine.”

Collaboration with Elekta

The key objective of the collaboration with Elekta is to advance MR-linac technology and its application as the radiation therapy with superior precision, medical outcomes, and operational cost efficiency. The companies intend to facilitate clinical studies exploring the impact of MR-guided therapy in oncology and work jointly to expand the potential role of MR-guided therapy into other areas that could benefit from the technology. The companies are also exploring initiatives such as the formation of a cooperative group and working on healthcare policy. The collaboration is subject to the execution of definitive documentation.

In connection with the collaboration, Elekta has committed to invest capital for up to a 9.9% minority interest in ViewRay. Elekta’s investment in ViewRay is subject to the terms and conditions set forth in a commitment agreement, including the condition of consummation of an equity capital raise of at least $75 million. In addition, Elekta’s investment in ViewRay is subject to an aggregate cap of $36 million.

“We believe that ViewRay and Elekta can work together to drive broad adoption of MR-linacs,” said Scott Drake, President and CEO of ViewRay. “We look forward to further promoting this technology to benefit patients worldwide.”

“Two companies actively promoting the implementation of the MR-linac technology in the market and collaborating on clinical applications will benefit clinicians and their patients with better and wider treatment options, improved outcomes, and lower costs,” said Richard Hausmann, Elekta’s President and CEO.

Ambra Health Announces Partnership with RAPID

Ambra Health Announces Partnership with RAPID

Ambra Health, makers of the leading medical image management suite, announced a partnership with RAPID, the worldwide leader in advanced imaging for stroke. The partnership enables cloud deployment of the RAPID stroke imaging platform and secure sharing of RAPID images across networks utilizing Ambra’s Best-in-KLAS image exchange capabilities.

The Ambra Health platform offers hospital networks the ability to receive and exchange imaging with ease, widen referral networks, and increase the availability of imaging data so that it can be used for research, AI, and machine learning innovations. Enabling access to imaging across departments and facilities is critical to speeding up communication among medical staff and improving patient care.

RAPID is the defacto worldwide standard in advanced imaging for stroke. Installed in over 1,400 hospitals, RAPID (automated CTP, MRI, CTA, ICH, and ASPECTS), with its enhanced AI framework, is the most comprehensive stroke imaging platform.

To provide RAPID customers a choice of deployment options, Ambra has installed a dedicated RAPID server in the Ambra data center to enable seamless integration between Ambra’s image management platform and the RAPID stroke imaging platform. Aided by this new cloud-based deployment model, a multi-facility customer can choose to run data through the RAPID platform without maintaining RAPID servers locally at all of their facilities. Additionally, Ambra will waive the RAPID integration fees for RAPID customers.

“The partnership allows facilities to easily expand the availability of RAPID across their networks. Time is brain when it comes to stroke care, and we’re confident that this partnership will enable additional flexibility in the deployment of RAPID’s incredible technology,” said Andrew Duckworth, VP of Business Development at Ambra Health.

“By enabling on-premise as well as cloud deployment of RAPID, hospitals can deliver our proven stroke imaging platform to their stroke teams in any way that works best for them,” said Anil Singhal, MD, SVP, Worldwide Operations at RAPID. “This partnership with Ambra symbolizes our commitment to our customers and empowering them to provide the best patient care.”

Together, the RAPID platform and Ambra Health’s image management suite supply one more option for facilities to view stroke imaging instantaneously and provide physicians and researchers with the information needed to transfer patients across facilities, enroll patients in clinical trials, and reduce overall time-to-care delivery.

Those interested in learning more about Ambra Health’s imaging solutions and the Ambra Health and RAPID partnership can receive a live demo at Booth #1342 during the upcoming Radiological Society of North America (RSNA) annual conference on December 1 – 6 in Chicago, Illinois. To make an appointment or for more details, visit the Ambra Health website.

About Ambra Health
Ambra Health is a medical data and image management SaaS company. Intuitive, flexible, scalable and highly interoperable, the Ambra cloud platform is designed to serve as the backbone of imaging innovation and progress for healthcare providers. It empowers some of the largest health systems as well as radiology practices, subspecialty practices, and clinical research organizations to dramatically improve imaging and collaborative care workflows. As expert partners, we listen to our customers, understand their needs, and apply our extensive knowledge to deliver innovative medical image management solutions for the future of healthcare, now. Discover what the Ambra medical imaging cloud can do for you at www.ambrahealth.com.

About RAPID
RAPID is the worldwide leader in advanced imaging for stroke. Installed in over 1,400 hospitals, RAPID (automated CTP, MRI, CTA, ICH, and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform. In clinical trials, RAPID has been shown to aid in the selection of patients in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world. For more information, visit RAPID at RSNA Booth #10537A or at www.RAPID.ai.

 

Merit Medical Introduces SCOUTShare Value Model

Merit Medical

Merit Medical announced it will introduce SCOUTShare™, a risk-sharing solution for wire-free localization at the 105th Annual Radiological Society of North America (RSNA) in Chicago, IL, to be held December 1-4, 2019.

SCOUTShare is a risk-sharing model designed to support radiologists in placing a SCOUT® reflector at the time of biopsy for highly suspicious lesions (BI-RADS 5). SCOUT is an advanced, radar localization system designed to improve the precision and predictability of marking breast lesions, biopsy sites and lymph nodes prior to or after neoadjuvant therapy and at surgery. As part of the SCOUTShare solution, Merit shares the risk if SCOUT localized patients do not progress to surgery at your facility by rebating those reflectors placed up to 5% of total purchases.

Specifically, the SCOUTShare value model can help spare a surgical patient an additional localization procedure prior to surgery. In many cases, using radar localization contributes to a more efficient healthcare ecosystem and addresses increasingly relevant concerns about clinical outcomes, patient experience and the per capita cost of care.

“SCOUTShare allows physicians managing breast care patients to place a SCOUT device at time of biopsy for highly suspicious lesions with the greatest likelihood of progressing to surgical management,” said Mary K. Hayes, MD, clinical assistant professor, Florida International University Herbert Wertheim School of Medicine. “This eliminates the need for an additional interventional procedure prior to surgery, directly benefiting patients, and provides excellent value for health systems looking to reduce operational and financial redundancy.”

On December 2 and 3 at RSNA, Merit Medical will host a series of hour-long THINK Wire-Free™ workshops focusing on the advanced applications of wire-free breast tumor localization. Radiologists Mary K. Hayes, MD and Tanya Mosley, MD, clinical professor, Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, will serve as faculty. These workshops are part of the ongoing Think Wire-Free educational platform. RSNA attendees can register online for this program, as well as other upcoming Think Wire-Free programs, at www.merit.com/thinkwirefree.

All RSNA attendees are invited to visit Merit Medical during the conference at booth #3352 in the South Hall, where the SCOUT technology, the Pink Achieve™ automatic biopsy device and the Biopsafe® Biopsy Sample System will be showcased.

About SCOUT®

The SCOUT Radar Localization System is used for breast surgical localization, before or after neoadjuvant chemotherapy, and to mark a biopsy site. The SCOUT reflector has a clinically insignificant MRI artifact, it does not interfere with MRI studies, so there is no restriction on the imaging modalities that can be used effectively throughout treatment. With 30 published clinical articles and abstracts, the SCOUT system has been proven to be easy to use and provides accurate detection and precise localization. To date over 100,000 women have had a SCOUT wire-free localization. SCOUT also has been shown to improve radiology workflow and significantly reduce OR delays. SCOUT has received recognition from medical societies and industry associations including the ASBS Scientific Impact Award, the Gold Award for Medical Design Excellence Award and the Premier Innovation Award.

About Merit

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 6,350 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

 

Hacking Away at the Effects of Stress on Health: How Insurance Plays a Role

Terumo BCT Offers $100,000 Research Grant Supporting Patient Access to Care

The effects of stress on human health is not a new phenomenon, and yetso many of us fall prey to those effects every year. What makes matters worse is the fact that those that do fall sick because of physical and emotional stress often get worse due to further stress.This is often a direct result of thinking about the forthcoming cost of treatment, which in the US is among the highest in the world, unfortunately.

Having health insurance, however, has been found to have a hugely positive effect on stress reduction, both before and after the development of a health concern. To know more about the effects of stress, how to counter it, and what role health insurance plays in curbing those effects, go through the following.

Defining Stress

People often ignore the effects of stress because they do not understand what it is exactly, and how it can ruin the human body in no time. Therefore, a definition will certainly help pinpoint the problem itself.

Stress is the physical and mental response to a scenario that threatens our wellbeing in any direct or indirect manner. Depending on the kind of stress that we are discussing and the stressors concerned, this can be a fight or flight response with an excess adrenalin rush, but it could also be a lingering effect inside our mind, when the stressor is more long-term in nature, rather than being just immediate.

Physical Stress Vs. Mental Stress

Although there is a clear distinction between physical and mental stress, one can bring about the other, or worsen the effects of the concerned stressor significantly.

Physical Stress – Any physical activity that stresses the body in any way can be termed as physical stress, however, that’s more useful than harmful in most situations.

A planned exercise routine, for example, stresses the body but reduces the harmful effects of stress at the same time through the release of endorphins. But, if the body is overstrained regularly at work while playing sport or even at the gym, the exercise will become counterproductive and add to the generally harmful effects of stress.

Mental Stress – Mental stress is the main issue and the primary problem that affects human health in the worst way possible. Our perception and consequent reaction to stressful scenarios exhausts the body by bringing about physical stress in an unhealthy manner.

For example, police officers are far more likely to experience the many negative effects of physical and mental stress than most civilians, due to the nature of their jobs. However, at the same time, having health and life insurance policies designed specifically for dangerous professions such as police work

directly reduces the impact of job-related stress because it changes a cop’s perception of dangerous situations.

Since stress is a direct effect of our perception of a threatening situation, it is a regular scenario for police officers. However, when the financial assurance of a health insurance andlife insurance policy is there to reassure the officer that they will be taken care of if they get injured on the job, and their families will have financial support in the worst-case scenario, the stress dissipates to a great degree, as a natural effect of the assurance.

What are the Harmful Effects of Stress?

Once again, the effects largely depend on the nature of the stress, as well whether it’s just physical/mental or both. Nevertheless, most of the harmful effects eventually match and some of the most significant ones can be summarized as follows.

  • Compromised immune system; increased susceptibility to colds, infections, and diseases in general
  • Depression, anxiety, anger issues, irritability, inability to focus and other cognitive impairments
  • Lethargy, headache, insomnia or poor sleeping patterns and habits
  • Gastrointestinal issues (IBS, flatulence, and acid reflux are common) and loss of appetite
  • Overeating tendencies, addictive tendencies, substance abuse
  • Weight gain and other carcinogenic factors

Regular, conscious and targeted actions taken to counter stress are, by far, the most effective way to control its effects on our health. We cannot always control the stressors, but the effects of those stressors can be managed with significant success, as long asan effort is made.

5 Pharmacy Market Trends Medical Professionals Need to Know

The medical industry is rapidly evolving, and the pharmaceutical industry is no exception. However, there are specific trends affecting the pharmacy industry, and if you prepare for these trends before they completely revolutionize the industry, you’ll remain ahead of the competition. Here are 5 pharmacy market trends medical professionals and pharmacy managers need to know. We’ll also discuss how you can adapt to these market trends and maximize your profit margin.

The Explosion in Specialty Drugs

Specialty drugs are exploding, and the price of each is rising. Yet patients expect to be able to order them as seamlessly from pharmacies as name brand drugs. You need relationships with specialty pharmacies that dispense these drugs so you don’t lose customers who want to be able to order these drugs from the same place they get their other prescriptions.

You must also get the necessary certifications for health plans to reimburse you for these drugs. One option is joining the limited distribution network. The other is becoming an accredited specialty pharmacy yourself. It is worth the effort to be able to serve these patients, because one industry survey suggests that forty percent of all pharmacy revenue will come from specialty drugs in the next few years.

The Rise of Next Door Healthcare

Consumers are accustomed to on-demand entertainment, and they increasingly expect on-demand care. You need to be available to patients through whatever channel they prefer. Providing notices via text messages or apps that their prescription is available is a start. Being able to answer their questions almost immediately via an app and monitoring their adherence to medication regimens should be a priority. A side benefit of care management by pharmacists is that you will see your clients more often.

The Growth of Specialty Services

Pharmacies are starting to provide extra services to consumers. These services help them generate additional revenue and improve their engagement with customers. A common add-on service is weight management assistance. Another is giving people travel vaccinations. These add-on services give you an edge when you’re appealing to niche markets. Train your staff to provide advice to patients on over-the-counter and alternative regimens, but ensure that they know when to recommend someone see a physician as well.

The Pressure to Cut Costs

Patients are seeking alternative ways to treat themselves. This is increasing demand for over-the-counter remedies for issues generally treated by prescription medication. Your pharmacy staff must be able to answer questions about over-the-counter remedies. You can also earn extra business if you can provide cheaper alternatives.

For example, you could stock your pharmacy with essential oils and vitamins that these patients are seeking. If you work with a company that specializes in capsule fillers, you can make your own supplements. This helps patients save half or more off the cost of name brand vitamins and allows you to offer customized blends for patients as well. The ability to make capsules on demand also allows you to create products and see if there is a demand for them, and you don’t have to spend thousands of dollars on machinery you may not use in the future.

The Rise of Technology and Data Driven Decisions

Data and analytics are increasingly important across the board. Pharmacies are no exception. You should set up a point of sale system so that you can close on sales when someone is standing in the aisle instead of forcing them to walk to the register. Track revenue by product and service so that you never run out of products. Use big data to collect detailed information about your clients so you can recommend related products, increasing revenue per client while seeming to offer them an additional level of service. Or learn what incentives and rewards increase sales at minimal cost.

You can also monitor patient compliance or give individualized advice based on what medication schedules patients are most likely to stick with. It can also flag potential addicts and help you meet more stringent regulations regarding the management of pain meds. In short, combining the right technology and data analysis will help you make better clinical, financial and operational decisions.

Retail pharmacies can adapt to a changing industry and evolving customer expectations if they take steps now to remain ahead of these trends. Make the right decision, and you’ll gain a loyal customer base that will refer people to you over the pharmacy chain down the street.

OCN ConnectedCare Adds Mike Bourland to the CareDirect Team

OCN ConnectedCare Adds Mike Bourland to the CareDirect Team

OCN ConnectedCare (OCN CC) announces that Mike Bourland has joined the team as an advisor who will help shape the future of OCN CC’s CareDirect program, which is revolutionizing virtual health and strengthening localized care through innovative enhancements.

“Mike is an entrepreneur who brings a wealth of management experience in urgent care and employee population health,” said OCN CC CEO Brian Slusser. “Mike will help CareDirect bridge practicality gaps in healthcare, embracing innovation that enables better community health.”

CareDirect uses state-of-the-art technology to allow doctors to provide high-quality care to more patients through remote appointments, increasing access to healthcare in rural areas and to those who can’t travel to a major medical center. In a virtual CareDirect appointment, a high-definition screen allows doctors to observe a patient’s symptoms, ask questions and provide the same care they would at a hospital.

Bourland brings decades of healthcare experience to CareDirect, particularly in the urgent care field. He founded multiple healthcare organizations, and most recently served as president of ExpressMed, a central Ohio urgent-care facility. In his new role, Bourland said he sees a chance to advance both the efficiency and technology of the urgent care field.

“I’ve been involved in healthcare management my whole career, and I’m very excited to be working with CareDirect,” Bourland said. “My primary objective is to get the urgent care world to serve as an employer-sponsored service where physicians are connected to employers via virtual technology. We want to help urgent cares develop the network of connected spaces that can efficiently deliver clinician visits to employers.”

OCN CC is an organization of business leaders, innovators, clinicians, pharmacists, scientists, engineers and healthcare consumers who believe it’s possible to create a better consumer model for efficient access to quality care.

That mission resonates with Bourland, who said he’s excited to use his urgent-care expertise to cater solutions to various types of facilities using the CareDirect model.

“I hope to lead a number of these operators in diversifying their services and getting into virtual technology and making a much stronger connection to employer services,” Bourland said. “I think I can personally make an impact because of my background and my experience as an operator myself. I know what these folks are going through and I know the kinds of services that can separate them from the pack.”

About OCN ConnectedCare:
OCN CC is a leading managed health organization in the United States that provides healthcare solutions for employers and business opportunities for providers that are part of the company’s Health In Motion Network.

OCN CC’s leadership has experience driving change and aggregating efforts toward innovation. Using their experience in virtual heath, OCN CC organizes market forces and delivery models to help shape the future of pharmacy and on-demand primary care, with the ultimate goal of improving patient care and provider-patient relationships.

Fovia Ai Launches XStream aiCockpit and XStream aiPlatform

Fovia Ai Launches XStream aiCockpit and XStream aiPlatform

Fovia Ai, Inc., a subsidiary of Fovia, Inc., a world leader in advanced visualization for nearly two decades and a preeminent provider of zero-footprint, cloud?based imaging SDKs announced the release of XStream® aiCockpit™ and XStream® aiPlatform™, enabling radiologists and clinicians to efficiently access AI results directly within their existing workflows.

XStream aiCockpit bridges the gap between AI algorithms and PACS by providing radiologists access to customized AI?driven workflows and visualizations that are readily launched from any PACS, worklist, dictation software or hospital system. XStream aiCockpit is 2D and 3D visualization software, accessible as a white?label product or through native integration, enabling efficient navigation and meaningful interaction with diverse AI results, real?time interactive tools and validation on local populations.

XStream aiPlatform is a vendor?neutral ecosystem that connects AI developers, PACS and hospital systems, enabling the efficient delivery of AI?driven tools to radiologists. The dynamic design of XStream aiPlatform allows PACS to maintain control over the complete AI workflow experience by selecting which algorithms should be made available, controlling the flow of the AI results, and allowing such results to be viewed with the rich visualization capabilities of the XStream aiCockpit or inside their own native PACS viewer.

Complementary products in Fovia Ai’s product suite include F.A.S.T.® AI Annotation, F.A.S.T.® AI Validation, F.A.S.T.® AI Workflows, F.A.S.T.® Interactive AI and F.A.S.T.® Interactive Segmentation, collectively providing tools to annotate, validate, modify, accept/reject, interact with and segment data. The flexible architecture of Fovia Ai’s product suite allows seamless integrations and takes full advantage of Fovia’s nearly two decades of radiology integration experience with a variety of partners across platforms, processors and operating systems.

See Fovia Ai’s complete product suite at the 105th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Dec. 1?Dec. 5, in Chicago (AI Showcase, Booth 10518). To arrange a demonstration or learn more, contact us.

About Fovia Ai
Fovia Ai, Inc. is a subsidiary of Fovia, Inc., a world leader in advanced visualization, a preeminent provider of cloud?based, zero?footprint imaging SDKs, and the developer of High Definition Volume Rendering®, XStream® HDVR® and F.A.S.T.® RapidPrint®. Fovia Ai’s flagship products, XStream® aiCockpit™ and XStream® aiPlatform™ enable radiologists and clinicians to efficiently access AI results directly within their existing workflows from any PACS, worklist, dictation software or hospital system. Complementary products in Fovia Ai’s product suite include F.A.S.T.® AI Annotation, F.A.S.T.® AI Validation, F.A.S.T.® AI Workflows, F.A.S.T.® Interactive AI and F.A.S.T.® Interactive Segmentation, collectively providing tools to annotate, validate, modify, accept/reject, interact with and segment data. The flexible architecture of Fovia Ai’s product suite and Fovia’s nearly two decades of radiology integration experience facilitate seamless integrations with a variety of partners, platforms, processors and operating systems.

For additional information and to learn more about commercial, academic or research licensing, visit fovia.com or fovia.ai.

1...662663664...1,125Page 663 of 1,125

About us

Hospital & healthcare Management is a leading B2B arena designed for the healthcare sector, it allow members to reach both ends of the healthcare facility procurement chain. . . Read More

Subscribe us

System

Resources

Archive Links

Subscribe

Copyright © 2008 - 2026 Hospital & Healthcare Management. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »